Viewing Study NCT01110668


Ignite Creation Date: 2025-12-24 @ 5:33 PM
Ignite Modification Date: 2025-12-26 @ 4:40 AM
Study NCT ID: NCT01110668
Status: COMPLETED
Last Update Posted: 2017-02-28
First Post: 2010-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastrointestinal Stromal Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Unresectable View
None metastatic gastrointestinal stromal tumor View
None disease progression View
None progression-free survival View